Contact Us | Visit imshealth.com | Français

Connected Solutions for You to Drive Healthcare Forward

BUDGET IMPACT ANALYSIS

SERVICE OBJECTIVE

BIA is a tool used to predict and understand the potential financial impact of introducing a new health care intervention into a health care system. This is accomplished by implementing comparative cost-determination analyses for competing scenarios, both including and excluding the product of interest

DETAILS

  • Evaluates the financial implications of the listing of the product
  • Does not consider the clinical benefits (PE analysis)
  • Captures a 3-year period forecast after the reimbursement
  • Cost are not adjusted for inflation or discounts
  • PMPRB/ISPOR Guideline

APPLICATIONS AND CLIENT VALUE

  • New Molecular Entity
  • Combination of existing molecules
  • A Drug with a New Indication(s)
  • Line extension
  • A listed drug for which expansion of the reimbursement criteria is sought
  • Submission to private drug plans

Health Access & Outcomes

Privacy   |   Terms of Use    Copyright © 2016 IMS Health Incorporated. All rights reserved.